These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10681612)

  • 1. Paronychia with pyogenic granuloma in a child treated with indinavir: the retinoid-mediated side effect theory revisited.
    Sass JO; Jakob-Sölder B; Heitger A; Tzimas G; Sarcletti M
    Dermatology; 2000; 200(1):40-2. PubMed ID: 10681612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paronychia and pyogenic granuloma of the great toes in patients treated with indinavir.
    Bouscarat F; Bouchard C; Bouhour D
    N Engl J Med; 1998 Jun; 338(24):1776-7. PubMed ID: 9625645
    [No Abstract]   [Full Text] [Related]  

  • 3. Indinavir-related recurrent paronychia and ingrown toenails.
    Alam M; Scher RK
    Cutis; 1999 Oct; 64(4):277-8. PubMed ID: 10544885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paronychia in association with indinavir treatment.
    Colson AE; Sax PE; Keller MJ; Turk BK; Pettus PT; Platt R; Choo PW
    Clin Infect Dis; 2001 Jan; 32(1):140-3. PubMed ID: 11118393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indinavir-induced retinoid-like effects: incidence, clinical features and management.
    García-Silva J; Almagro M; Peña-Penabad C; Fonseca E
    Drug Saf; 2002; 25(14):993-1003. PubMed ID: 12408731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Paronychia in patients infected with HIV treated with indinavir].
    García García MJ; Morano Amado LE; Allegue Rodríguez F; Miralles Alvarez C; Ocampo Hermida A
    Rev Clin Esp; 2001 Aug; 201(8):455-8. PubMed ID: 11599157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease inhibitor-related paronychia, ingrown toenails, desquamative cheilitis and cutaneous xerosis.
    García-Silva J; Almagro M; Juega J; Peña C; López-Calvo S; del Pozo J; Fonseca E
    AIDS; 2000 Jun; 14(9):1289-91. PubMed ID: 10894302
    [No Abstract]   [Full Text] [Related]  

  • 8. Paronychia and excess granulation tissue of the toes and finger in a patient treated with indinavir.
    Daudén E; Pascual-López M; Martínez-García C; García-Díez A
    Br J Dermatol; 2000 May; 142(5):1063-4. PubMed ID: 10809885
    [No Abstract]   [Full Text] [Related]  

  • 9. Ureteral obstruction secondary to indinavir in the pediatric HIV population.
    Noble CB; Klein LT; Staiman VR; Neu N; Hensle TW; Berdon WE
    Pediatr Radiol; 1998 Aug; 28(8):627-9. PubMed ID: 9716639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary necrosis associated with the HIV protease inhibitor indinavir.
    Dieleman JP; van der Feltz M; Bangma CH; Stricker BH; van der Ende ME
    Infection; 2001 Aug; 29(4):232-3. PubMed ID: 11545487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indinavir/low-dose ritonavir containing HAART in HIV-1 infected children has potent antiretroviral activity, but is associated with side effects and frequent discontinuation of treatment.
    Fraaij PL; Verweel G; van Rossum AM; Hartwig NG; Burger DM; de Groot R
    Infection; 2007 Jun; 35(3):186-9. PubMed ID: 17565462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crixivan side effect update - hair loss and ingrown toenails.
    Fornataro K; Jefferys R
    Body Posit; 1999 Oct; 12(10):12. PubMed ID: 11366875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indinavir use: associated reversible hair loss and mood disturbance.
    Harry TC; Matthews M; Salvary I
    Int J STD AIDS; 2000 Jul; 11(7):474-6. PubMed ID: 10919491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evidence-based therapeutic drug monitoring for indinavir].
    Barrail-Tran A; Taburet AM; Poirier JM;
    Therapie; 2011; 66(3):239-46. PubMed ID: 21819808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent sterile leukocyturia is associated with impaired renal function in human immunodeficiency virus type 1-infected children treated with indinavir.
    van Rossum AM; Dieleman JP; Fraaij PL; Cransberg K; Hartwig NG; Burger DM; Gyssens IC; de Groot R
    Pediatrics; 2002 Aug; 110(2 Pt 1):e19. PubMed ID: 12165618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidural lipomatosis secondary to indinavir in an HIV-positive patient.
    Cersósimo MG; Lasala B; Folgar S; Micheli F
    Clin Neuropharmacol; 2002; 25(1):51-4. PubMed ID: 11852297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute respiratory failure associated with the human immunodeficiency virus (HIV) protease inhibitor indinavir in an HIV-infected patient.
    Dieleman JP; in 't Veld B; Borleffs JC; Schreij G
    Clin Infect Dis; 1998 Apr; 26(4):1012-3. PubMed ID: 9564505
    [No Abstract]   [Full Text] [Related]  

  • 18. Acquired reactive perforating collagenosis induced by indinavir in 2 patients with HIV disease.
    Calista D; Morri M
    Eur J Dermatol; 2008; 18(1):84-5. PubMed ID: 18086600
    [No Abstract]   [Full Text] [Related]  

  • 19. Indinavir (Crixivan).
    Res Initiat Treat Action; 2000 Mar; 6(1):28-9. PubMed ID: 11708184
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction between levothyroxine and indinavir in a patient with HIV infection.
    Lanzafame M; Trevenzoli M; Faggian F; Marcati P; Gatti F; Carolo G; Concia E
    Infection; 2002 Jan; 30(1):54-5. PubMed ID: 11876520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.